GENOCEA BIOSCIENCES, INC.
CIK 0001457612
Revenue (TTM)
$308K
+1,440.0% YoY
Q1 Apr 2022
Net Income (TTM)
−$35.89M
+24.1% YoY
Q1 Apr 2022
EPS Diluted (TTM)
−$0.64
+56.8% YoY
Q1 Apr 2022
Gross Margin
—
Q1 Apr 2022
Operating Margin
-17,680.8%
Q1 Apr 2022
Net Margin
-11,653.9%
Q1 Apr 2022
Free Cash Flow (TTM)
−$54.22M
Q1 Apr 2022
Cash
$20.14M
Q1 Apr 2022
Total Debt
$7.65M
Q1 Apr 2022
Shares Outstanding
58.78M sh
Q1 Apr 2022